Labthermics Technologies Inc Profile last edited on: 11/8/11
CAGE:
UEI:
Business Identifier: NO Business Identifier is currently available for this company. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 13
County: Champaign
Congr. District: 13
County: Champaign
Public Profile
Labthermics Technologies, Inc. is a medical therapy products company dedicated to improving cancer treatment. Over the past ten years, the Company has become a fully faceted corporation with a series of unique cancer therapy products -- the first of which received FDA approval in September 1989. The firm's first commercial therapy product, the SONOTHERM 1000, is the most technologically advanced hyperthermia device available. Since the SONOTHERM can treat larger and deeper tumors, it can effectively treat three times as many patients as competing hyperthermia systems. Its unique multi-sectored therapy applicator design and adaptive control system enable it to shape the energy field to match the tumor size and shape, which results in more effective heating than that provided by competing systems.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 1997 | 2 | NIH | $752,866 | |
| Project Title: Second generation commercial ultrasound therapy arrays | ||||
| 1996 | 1 | NIH | $100,000 | |
| Project Title: Site-Specific Microwave Applicators For Hyperthermia | ||||
| 1995 | 1 | NIH | $100,000 | |
| Project Title: Sparse Random Ultrasound Phased Arrays for Focal Surgery | ||||
| 1990 | 2 | NIH | $550,000 | |
| Project Title: Tapered linear phased array for ultrasound hyperthermia | ||||
| 1989 | 2 | NIH | $550,000 | |
| Project Title: Microwave phased array for hyperthermia cancer theraphy | ||||
Key People / Management
Stephen A Goss
Ronald L Johnston
Andrew S Jones
Ronald L Johnston
Andrew S Jones
Company News
There are no news available.
